Amsulostat
安卢司他
Report date: 2026/04/17 20:02:02
NME
Base Information
Drug NameAmsulostat
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSyntara Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSyntara Ltd
Inactive CompaniesUniversity Of Rochester
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A